I can’t believe that it has been almost 9 months since my
last update. So, first things first. Yes, I am alive, well and still kicking. End of Short Report.
The world is still a very strange place, not at all what we
were used to a year ago. As an
immunocompromised patient I have been a little more careful than the general
population because the preliminary statistics for CLL patients that are hospitalized,
is pretty grim. Between 25-30%
mortality. Granted this information is
from very early in the pandemic and the courses of treatment have changed for
the better, but it still gives me pause to be cautious. Bottom line, ‘stay out of the hospital’.
But, as with everyone, the world doesn’t stand still. I still have doctor appointments, some I can
do via telemedicine, but some have to be done in person. I had a long overdue colonoscopy in May and
it was a good thing I did, as they found 7 polyps (all benign) and they removed
them. I do need to make a dentist and eye appointments, which were put off
because of the pandemic.
One sad piece of news is that my father, Paul Henry Evans,
passed away in September. He was almost 94
years old and had been in failing health for about 6-12 months. He did not die of COVID, but his passing was a
huge loss for the family. We could not
have a funeral, so we had a Zoom memorial service which was nice in some ways,
but very sad in other ways. He will be
greatly missed by many.
So, to update my CLL journey, here is a refresher. I won’t go back to 2000, the year I was
diagnosed, but will start with my last 2 (out of 6) treatments. If you remember, in 2013 I was allowed to
crossover and start taking a new class of drug called Ibrutinib. I was part of the Clinical Trial the FDA used
to approve the drug for all CLL patients.
I had very good luck with Ibrutinib and remained in Clinical Remission
until January 2018, or 4 ½ years after I started. In January of 2018 things started to change
very slowly, and both myself and my doctor could tell that I was relapsing,
even if it was at a very slow pace. I
started look around for my next steps and was disappointed to find that there
were almost NO options for a patient with my treatment background. Because of prior treatments I was excluded
from almost every option of treatment. I
guess my situation got my doctor’s attention because he CREATED what is called
an Investigator Initiated Clinical Trial.
This is a case where the medical team proposes the treatment protocol
and the drug companies agree to let them initiate it. I wound up being patient #1 on this
trial. The new trial allowed me to stay
on Ibrutinib, mainly because it was still working, just not as well as before,
and because he wanted to add another drug (Venetoclax) to see if there could be
some synergy using both drugs at the same time.
There had already been some preliminary studies at this time that had
shown that they worked together in front line settings, but not much data on
people like me, in a relapsed setting.
As you may have read in previous posts, this combination for me, was
amazing. Within weeks of starting
Venetoclax, my blood numbers were all back in normal range. After several months there was a test done to
see if they could find ANY CLL cells and the test came back negative.
This was all great news, but we had to now figure out what
to do. I know this may seem strange to
many of you, because the logical thing to say is ‘keep doing, what you are doing’. But it is never as simple as that. Most of the trials that had been done with
Venetoclax had been done in what is called a ‘fixed duration’ setting. Which means, you take it until you test
Negative for disease, and then you stop.
I think the main reason that this was done, is if you continue taking
it, would there be a possibility that even if you are negative, would you
develop resistance to the drug after some period of time? Because my particular situation does not fit
into one of the categories that were done in earlier trials, we had to decide
on what to do after I became Minimal Residual Disease Undetected (of
MRDu). So, we kept on having tests to measure
for disease, first in the peripheral blood and then thru a deeper test using
the bone marrow. Tests were run at different
intervals and they all have come back negative.
But in October of 2020 we were at a decision point. ‘how much value was I getting by staying on
Venetoclax?’. The short answer is that no
one knows. But a couple of points led me
to a decision that I should stop the Venetoclax, but remain on Ibrutinib.
First off, I had not relapsed on Venetoclax. It was still effective. If I had relapsed while on Venetoclax, we would
know that it had STOPPED working and I would have to find another class of drug. There were also some studies published in
December that in a small group of patients that stopped Venetoclax while they
still had no disease, and then relapsed, they were able to RESTART Venetoclax
and they mostly had very positive results upon restarting.
Secondly, I had to pay for the Venetoclax on the trial (the
Ibrutinib was paid for by the pharmaceutical company). It is a very expensive drug, retail cost
about $12,000 / month. If you don’t have
Medicare Part D for prescription drug coverage, forget it. Luckily, I do have a Part D plan, even with
that and falling into what they call Catastrophic Coverage in the FIRST month
of the prescription, you still have a lot of out-of-pocket expenses (about
$10-12,000) per year. The coverage is
base on Calendar year, no matter when you started. So, in my case, this bill would have hit in
January 2021.
Thirdly, I was still having some Adverse Events (fancy name
for side effects) that we were not able to control completely. I won’t go into detail, but let’s just say I
had some GI issues. So, stopping the
Venetoclax would hopefully clear those up as well.
Based on all of that, we decided to stop the Venetoclax on
December 31, 2020. Now the real question
(and the reason for this post) is what will happen to my CLL after I stop. I am happy to inform everyone that I just got
the results back from the test that was done on March 10th and they
still cannot find any disease.
Good news for sure, but it is never the end. The question is what happens when I relapse
again? Certainly, my situation was not
as dire as it was in January 2018, when there just weren’t many options, but
there still needs to be a plan in place as to what to do when that happens. My first option would to go back on
Venetoclax and see if it would work again.
My second option would be to look at a third-generation version of Ibrutinib. This newer version is supposed to ignore the
mutation that caused me to start relapsing on Ibrutinib. There are also several new and exciting drugs
that are in Clinical Trials, but I don’t know if I would qualify for one of
them or not. My last option, but maybe
the most important one that I am considering is something I have mentioned
before called CAR T therapy. It is in
Clinical Trials right now and has the potential of completely getting rid of the
disease. I know of several people that
have done this and they are disease free after 3 years. This one certainly looks like a potential ‘cure’. There are no guarantees with this treatment
as it doesn’t work for everyone, but it is certainly on my radar and actually
have an appointment in April with a doctor at City of Hope that specializes in
this treatment for CLL patients.
I know there is a lot of talk about the COVID vaccine and
how it may be a way out of this pandemic, but for those of us that are immune
compromised it is still not a pretty picture.
Because our immune system doesn’t work the way that it does in normal
people (I’m not saying I’m abnormal, just different), we really don’t know if
we will develop any response to a vaccine.
This is not only true for the COVID vaccine, but also for pneumonia,
flu, tetanus, etc. I hope I got some
response to the vaccine, but only time will tell how effective it really is
going to be, how long it will last, and will we have to get another one next
year, like the Annual Flu Shot.
I am still involved in Patient Advocacy and still leading my
support group. I have also been involved
in several online webinars with teams of doctors discussing the patient’s role
in dealing with CLL. I have been
interviewed for two podcasts, one published, and one yet to be published where
I discuss my journey. Here is a link to
the Podcast that was done for THE
GREG KRINO SHOW (Click the link to listen
to the show). Greg has created a Podcast
where he interviews people that have had interesting life experiences. I was fortunate to have been interviewed by him
for his show. Check out his list of over
30 Podcasts. His Facebook Link The Greg Krino Show Facebook
Page .
See you again in another 6 months or so…ha ha. I hope you all stay well.
Terry